Navigation Links
Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables
Date:4/9/2009

Issued and outstanding: 42,893,928 (2007 - 40,305,028) Subscriptions received -- 9,170 Additional paid in capital 41,629,506 32,109,997 Accumulated other comprehensive income 3,773,224 1,956,456 Dedicated reserves 5,549,684 2,999,396 Accumulated deficit (1,281,534) (7,111,469) Total stockholders' equity 49,713,775 30,003,855 Total liabilities and stockholders' Equity $ 83,203,222 $ 57,447,962 The accompanying notes are an integral part of these consolidated financial statements. SINOVAC BIOTECH LTD. Consolidated Statements of Income and Comprehensive Income Three Months and Twelve months Ended December 31, 2008 and 2007 (Unaudited) (Expressed in U.S. Dollars) Three months ended Twelve months ended December 31, December 31, 2008 2007 2008 2007 Sales $12,359,803 $9,201,946 $46,496,904 $33,541,187 Cost of sales - (exclusive of depreciation of land-use rights and amortization of licenses and permits of $104,000 [2007 - $96,296] for three months and $411,065 [2007- 376,184] for twelve months) 4,615,674 2,915,135 9,936,341 6,502,328 Gross profit 7,744,129 6,286,811 36,560,563 27,038,859 Selling, general and administrative expenses 4,054,222 2,472,518 17,462,674 11,958,498 Research and development expenses - net of $162,064(2007- $401,935) for three months and $310,222 (2007- $843,910) for twelve months in government research grants
'/>"/>
SOURCE Sinovac Biotech Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related biology technology :

1. Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results
2. Sinovac to Host Conference Call to Report Fourth Quarter and Full Year 2008 Financial Results
3. Sinovac Biotech Co. Ltd., Sinovacs Beijing Subsidiary, Obtains High-Tech Enterprise Status
4. Sinovac Receives GMP Certification for its New Filling and Packaging Production Facility
5. Sinovac Enters Veterinary Vaccine Market with Inactivated Rabies Vaccine
6. Sinovac Releases Statement on Healive Vaccine Suspension
7. Sinovac Reports Third Quarter 2008 Unaudited Financial Results
8. Sinovac Named to Deloitte Technology Fast 50 China
9. Sinovac to Participate in Two Upcoming Investor Conferences
10. Sinovacs Credit Rating Upgraded to AAZ, Second Highest Rating
11. Sinovac Biotech Holds 2007 Annual General Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... , March 2, 2015 ... to bottom.   Moments ago, Analysts Review ... Sunshine Heart (NASDAQ: SSH ), Synergetics ... Syneron Medical (NASDAQ: ELOS ), Spectranetics (NASDAQ: ... Analysts Review provides a single unified platform for investors, to ...
(Date:3/2/2015)... , March 2, 2015 VG ... developing therapies for autoimmune and infectious diseases, announced ... has issued an important new composition of matter ... through the targeting of CLIP. ... technology underlying VG Life Sciences, VG1177, a synthetic ...
(Date:3/2/2015)... MIAMI (PRWEB) March 02, 2015 ... a newly formed alliance with Shenzhen HANK Bioengineering ... M.D., Ph.D. The alliance will establish a stem ... Guangdong Province, China in September 2015. , Shenzhen ... by Zhang, an award-winning scientist, microbiologist and virologist, ...
(Date:3/1/2015)... London, UK (PRWEB) March 01, 2015 ... a partnership agreement for quality market research promotion ... and sell research reports worked out by DataGroup ... Department at Market Publishers Ltd, commented on the ... to have DataGroup Booksellers in our team of ...
Breaking Biology Technology:Quarterly Report Card of Biotechnology Companies: New Research on Sunshine Heart, Synergetics USA, Syneron Medical, Spectranetics and Thoratec 2Quarterly Report Card of Biotechnology Companies: New Research on Sunshine Heart, Synergetics USA, Syneron Medical, Spectranetics and Thoratec 3Quarterly Report Card of Biotechnology Companies: New Research on Sunshine Heart, Synergetics USA, Syneron Medical, Spectranetics and Thoratec 4VG Life Sciences Granted Key Composition Of Matter Patent 2VG Life Sciences Granted Key Composition Of Matter Patent 3Global Stem Cells Group Announces Alliance with HANK Bioengineering Co., Ltd. in Shenzhen, China 2Global Stem Cells Group Announces Alliance with HANK Bioengineering Co., Ltd. in Shenzhen, China 3Market Publishers Ltd and DataGroup Booksellers Sign Partnership Agreement 2Market Publishers Ltd and DataGroup Booksellers Sign Partnership Agreement 3
... 24 GeneGo, Inc., the leading,systems biology ... licensed,MetaCore(TM). VTT develops novel high-throughput methods for ... is in investigating,mechanisms of cancer development and ... the mechanism of action of,anti-cancer compounds. VTT ...
... of nanotechnology to electronics, photonics and renewable energy will ... held from August 10 to 14, 2009 at McMaster ... will also be presented in conjunction with the event. ... Summer School (NGC2009) and the 14th Canadian Semiconductor Technology ...
... Physicists at UC Riverside have made an ... to change how information in computers can be ... electrons, a property electrons possess that makes them ... in the development of spin-based semiconductor technology such ...
Cached Biology Technology:VTT Technical Research Centre of Finland Licenses MetaCore from GeneGo for Cancer Research and Diagnostics 2Joint nanotechnology forum to focus on electronics, photonics, renewable energy 2Discovery by UC Riverside physicists could enable development of faster computers 2Discovery by UC Riverside physicists could enable development of faster computers 3
(Date:2/19/2015)... Research and Markets ( http://www.researchandmarkets.com/research/kx9zp8/military ... "Military Electro-Optical / Infrared Systems Market by Type, ... Forecast to 2020" report to their offering. ... is expected to reach $16.35 billion by 2020, ... This report segments the military electro-optical/infrared systems market ...
(Date:2/11/2015)... , February 11, 2015 ... research report "Access Control Market by Product (Cards and ... Residential, Military and Defense, Government, Industrial, Healthcare, Education) and ... published by MarketsandMarkets, the Access Control Market ... 2020, growing at a CAGR of 10.6% ...
(Date:2/5/2015)... 2015   Epic Sciences , a precision diagnostics company ... Murali Prahalad , Ph.D., president and CEO, is scheduled ... (PMWC) 2015: Silicon Valley, which is taking place at the ... on January 26-28, 2015. Dr. Prahalad ... Biomarkers." Last year, Epic Sciences was a finalist in the ...
Breaking Biology News(10 mins):Military Electro-Optical / Infrared Systems (Image Intensification, Laser, Infrared) Market - Forecast to 2020: Featuring Profiles of the Market Leaders on this $16 Billion market 2Military Electro-Optical / Infrared Systems (Image Intensification, Laser, Infrared) Market - Forecast to 2020: Featuring Profiles of the Market Leaders on this $16 Billion market 3Access Control Market Worth $10.4 Billion by 2020 2Access Control Market Worth $10.4 Billion by 2020 3Access Control Market Worth $10.4 Billion by 2020 4Epic Sciences to Present at Personalized Medicine World Conference 2015 on the Use of Circulating Tumor Cells as Cancer Biomarkers 2
... 6, 2011 -- One of the holy grails in diabetes ... and to find drugs that target these molecules. Now, JDRF-funded ... done both, discovering not only a protein that regulates beta ... The work appears in the September 7 issue of ...
... new discovery by the University of Colorado Boulder and ... tiny "power plants" within cells known as mitochondria has ... diseases and conditions due to mitochondrial defects. Led ... in collaboration with the UC-Davis team led by Professor ...
... Peripheral arterial disease, or PAD, is a common ... older that may be a signal of future heart ... unaware they have it, says the Society of Interventional ... of Interventional Radiology,s national screening program, Legs For Life, ...
Cached Biology News:Researchers identify new drug target that stimulates 2New cellular surprise may help scientists better understand human mitochondrial diseases 2Interventional radiologists: Learn about peripheral arterial disease and get moving 2Interventional radiologists: Learn about peripheral arterial disease and get moving 3
... EPS 1001 Power Supply, 1. ... maximum.Constant voltage, constant current, and constant ... read-outs for precision and reproducibility.Stores and ... ultrathin flatbed gels on Multiphor ...
Human CCL26/Eotaxin-3 MAb (Clone 115002)...
Prostaglandin E2 Luminex Standard Product Lines: Unspecified...
Request Info...
Biology Products: